Eurozone: a real growth or a simple bounce up?
A never-ending Quantitative Easing
According to what Mario Draghi claimed during the last press conference in Frankfurt, in the next few months the ECB will adapt its monetary policy to the better Euro-System conditions, even if it has decided to not change the expansive approach followed until today. Stepping back to the day before the press conference, we can […]
MONSANTO’S ACQUISITION: THIS IS BAYER’S AMBITION! WILL IT BE ABLE TO REACH ITS AIM?
Last week the European Central Bank announced it will be softening the impact of the Quantitative Easing program, reducing the bond purchases from 60 to 30 billion euros per month from January 2018. The net asset purchases are intended to continue at least until September 2018 or beyond as the continent’ s strengthening economy has not […]
Joint Contribution for the ECB-MC Model
Which are the best growth strategies for a company whose aims are to achieve economies of scale, expand its operation and find new profits’ sources? An acquisition could be a good answer! This is what Bayer is trying to do with Monsanto! But, what do these companies do? Let’s go deeper. Bayer is a German […]
“Policy models cannot be expected to have the same tight structure as theory models. […] Different classes of macro models are needed for different tasks.” (Olivier Blanchard) During the Annual Research Conference organised by the ECB on the 25th and 26th of September 2017, Vítor Constâncio, Vice-President of the ECB, held the opening speech. The meeting, […]